Association of estrogen receptor α and β3-adrenergic receptor polymorphisms with endometrial cancer

Obstetrics and Gynecology

Volumn 102, Issue 3, 2003, Pages 506-511

  Iwamoto, Ichiro ^a   Fujino, Toshinori ^a   Douchi, Tsutomu ^a   Nagata, Yukihiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; DNA; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CALCULATION; CANCER RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; ENDOMETRIUM CANCER; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT; RISK; RISK FACTOR; SAMPLE; AGE DISTRIBUTION; CASE CONTROL STUDY; COHORT ANALYSIS; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MENOPAUSE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROBABILITY; REFERENCE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

AGE DISTRIBUTION; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; JAPAN; MENOPAUSE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROBABILITY; RECEPTORS, ADRENERGIC, BETA-3; RECEPTORS, ESTROGEN; REFERENCE VALUES; RISK ASSESSMENT;

EID: 0141955809     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00578-7     Document Type: Article

References (24)

1. Imamura T., Arima T., Kato H., Miyamoto S., Sasazuki T., Wake N. Chromosomal deletions and K-RAS gene mutations in human endometrial carcinomas. Int J Cancer. 51:1992;47-52.
2. Honda T., Kato H., Imamura T., Gima T., Nishida J., Sasaki M., et al. Involvement of p53 gene mutations in human endometrial carcinomas. Int J Cancer. 53:1993;9963-9967.
3. Gima T., Kato H., Honda T., Imamura T., Sasazuki T., Wake N. DCC gene alteration in human endometrial carcinomas. Int J Cancer. 57:1994;480-485.
4. Yaich L., Dupont W.D., Cavener D.C., Parl F.F. Analysis of the Pvu II restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res. 52:1992;77-83.
5. Weiderpass E., Persson I., Melhus H., Wedren S., Kindmark A., Baron J.A. Estrogen receptor gene α polymorphisms and endometrial cancer risk. Carcinogenesis. 21:2000;623-627.
6. Krief S., Lonnqvist F., Raimbault S., Baude B., Van Spronsen A., Arner P., et al. Tissue distribution of β 3-adrenergic receptor mRNA in man. J Clin Invest. 91:1993;344-349.
7. Strosberg A.D. Association of beta 3-adrenoreceptor polymorphism with obesity and diabetes Current status . Trends Pharmacol Sci. 18:1997;449-454.
8. Walston J., Silver K., Bogardus C., Knowler W.C., Celi F.S., Austin S., et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic receptor gene. N Engl J Med. 333:1995;343-347.
9. Clement K., Vaisse C., Manning B.S., Basdevant A., Guy-Grand B., Ruiz J., et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 333:1995;352-354.
10. Widen E., Lehto M., Kanninen T., Walston J., Shuldiner A.R., Groop L.C. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 333:1995;348-351.
11. Yoshida T., Sakane N., Umekawa T., Sakai M., Takahashi T., Kondo M. Mutation of beta 3-adrenergic receptor gene and response to treatment of obesity. Lancet. 346:(8987):1995;1433-1434.
12. Sakane N., Yoshida T., Yoshioka K., Nakamura Y., Umekawa T., Kogure A., et al. Beta 3-adrenoreceptor gene polymorphism A newly identified risk factor for proliferative retinopathy in NIDDM patients . Diabetes. 46:1997;1633-1636.
13. Sakane N., Yoshida T., Umekawa T., Kogure A., Takakura Y., Kondo M. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care. 20:1997;1887-1890.
14. Sakane N., Yoshida T., Umekawa T., Kondo M., Sakai Y., Takahashi T. Beta 3-adrenergic-receptor polymorphism A genetic marker for visceral fat obesity and the insulin resistance syndrome . Diabetologia. 40:1997;200-204.
15. Giannone R., Bernorio R., Poli M. Risk factors of endometrial carcinoma. Minerva Ginecol. 45:1993;361-364.
16. Shihara N., Yasuda K., Moritani K., Ue H., Adachi T., Tanaka H., et al. The association between Trp64Arg polymorphism of the β 3-adrenergic receptor and autonomic nervous system activity. J Clin Endocrinol Metab. 84:1999;1623-1627.
17. Sasaki M., Tanaka Y., Kaneuchi M., Sakuragi N., Dahiya R. Polymorphisms of estrogen receptor α gene in endometrial cancer. Biochem Biophys Res Commun. 297:2002;558-564.
18. Haiman C.A., Hankinson S.F., Colditz G.A., Hunter D.J., Vivo I.D. A polymorphism in CYP17 and endometrial cancer risk. Cancer Res. 61:2001;3955-3960.
19. Berstein L.M., Imyanitov E.N., Gamajunova V.B., Kovalevskij A.J., Kuligina E.S., Belogubova E.V., et al. CYP17 genetic polymorphism in endometrial cancer Are only steroids involved? Cancer Lett. 180:2002;47-53.
20. Huang X.E.N., Hamajima N., Saito T., Matsuo K., Mizutani M., Iwata H., et al. Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Res. 3:2001;264-269.
21. Ueda K., Tanizawa Y., Oota Y., Inoue H., Kizuki N., Inoue H., et al. Prevalence of the Trp64Arg missense mutation of the β 3-adrenergic receptor gene in Japanese subjects. Metabolism. 46:1997;199-202.
22. Ostroumova M.N., Kovalenko I.G., Bershtein L.M., Tsyrlina E.V., Dilman V.M. Characteristics of dyslipidemia in cancer patients. Vopr Onkol. 32:1986;34-43.
23. Katsumata K., Nishizawa K., Unno A., Fujita Y., Tokita A. Association of gene polymorphisms and bone density in Japanese girls. J Bone Miner Metab. 20:2002;164-169.
24. Kobayashi N., Fujino T., Shirogane T., Furuta I., Kobamatsu Y., Yaegashi M., et al. Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas. 41:2002;193-201.